Oct 14, 2021
Hyderabad-based Dr Reddy's Laboratories has become the first Indian pharmaceutical company to launch an anti-cancer drug Abiraterone Acetate in the Chinese market, India's ambassador to China Vikram Misri said in a tweet on October 13.
The drug used in cancer treatment is a therapeutic equivalent generic version of Zytiga owned by Johnson & Johnson.
In China, Dr Reddy's Laboratories Ltd operates through its joint venture with Rotam Group of Canada. The joint venture is widely known as Kunshan Rotam Reddy Pharmaceutical Co Ltd. (KRRP).
A recent Edelweiss report revealed Dr Reddy's as the largest foreign player in China and hoped to launch about 60 products.
Besides China, Dr Reddy's operates in markets across the globe including, the USA, Russia, and Europe.